Cargando…

FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma

(18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is widely used for tumor staging. This study sought to determine the relationship of preoperative primary tumor SUVmax (tSUVmax) with the clinicopathological features of patients with OSCC and to compare the prognostic ability of tSUVma...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Nan-Chin, Su, I-Hsien, Hsu, Jui-Ting, Tsai, Kuo-Yang, Chen, Michael Y. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313663/
https://www.ncbi.nlm.nih.gov/pubmed/34312436
http://dx.doi.org/10.1038/s41598-021-94567-w
_version_ 1783729389302710272
author Lin, Nan-Chin
Su, I-Hsien
Hsu, Jui-Ting
Tsai, Kuo-Yang
Chen, Michael Y. C.
author_facet Lin, Nan-Chin
Su, I-Hsien
Hsu, Jui-Ting
Tsai, Kuo-Yang
Chen, Michael Y. C.
author_sort Lin, Nan-Chin
collection PubMed
description (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is widely used for tumor staging. This study sought to determine the relationship of preoperative primary tumor SUVmax (tSUVmax) with the clinicopathological features of patients with OSCC and to compare the prognostic ability of tSUVmax with that of other recurrence factors. Data of 340 patients with OSCC who were diagnosed, treated, and followed up at the Changhua Christian Hospital were retrospectively analyzed. Only patients with OSCC arising from gingiva, palate, floor of the mouth, and retromolar trigone and those who had received preoperative FDG-PET within 2 weeks before surgery were included. tSUVmax value > 9.2 was the strong predictor of bone invasion (area under the receiver operating characteristic curve, 0.844). tSUVmax value > 7.2 showed a strong association with advanced pathological T stage and recurrence factors and was associated with poor survival; tSUVmax > 7.2 showed stronger predictive power for poor disease-free survival (DFS) than pT stage and the other recurrence factors related to primary tumor. FDG-PET can be a useful supplement to contrast-enhanced computed tomography or contrast-enhanced magnetic resonance imaging for diagnosing bone invasion by OSCC. The tSUVmax value was an independent predictor of DFS in this study.
format Online
Article
Text
id pubmed-8313663
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-83136632021-07-28 FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma Lin, Nan-Chin Su, I-Hsien Hsu, Jui-Ting Tsai, Kuo-Yang Chen, Michael Y. C. Sci Rep Article (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is widely used for tumor staging. This study sought to determine the relationship of preoperative primary tumor SUVmax (tSUVmax) with the clinicopathological features of patients with OSCC and to compare the prognostic ability of tSUVmax with that of other recurrence factors. Data of 340 patients with OSCC who were diagnosed, treated, and followed up at the Changhua Christian Hospital were retrospectively analyzed. Only patients with OSCC arising from gingiva, palate, floor of the mouth, and retromolar trigone and those who had received preoperative FDG-PET within 2 weeks before surgery were included. tSUVmax value > 9.2 was the strong predictor of bone invasion (area under the receiver operating characteristic curve, 0.844). tSUVmax value > 7.2 showed a strong association with advanced pathological T stage and recurrence factors and was associated with poor survival; tSUVmax > 7.2 showed stronger predictive power for poor disease-free survival (DFS) than pT stage and the other recurrence factors related to primary tumor. FDG-PET can be a useful supplement to contrast-enhanced computed tomography or contrast-enhanced magnetic resonance imaging for diagnosing bone invasion by OSCC. The tSUVmax value was an independent predictor of DFS in this study. Nature Publishing Group UK 2021-07-26 /pmc/articles/PMC8313663/ /pubmed/34312436 http://dx.doi.org/10.1038/s41598-021-94567-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lin, Nan-Chin
Su, I-Hsien
Hsu, Jui-Ting
Tsai, Kuo-Yang
Chen, Michael Y. C.
FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
title FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
title_full FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
title_fullStr FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
title_full_unstemmed FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
title_short FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
title_sort fdg-pet predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313663/
https://www.ncbi.nlm.nih.gov/pubmed/34312436
http://dx.doi.org/10.1038/s41598-021-94567-w
work_keys_str_mv AT linnanchin fdgpetpredictsboneinvasionandprognosisinpatientswithoralsquamouscellcarcinoma
AT suihsien fdgpetpredictsboneinvasionandprognosisinpatientswithoralsquamouscellcarcinoma
AT hsujuiting fdgpetpredictsboneinvasionandprognosisinpatientswithoralsquamouscellcarcinoma
AT tsaikuoyang fdgpetpredictsboneinvasionandprognosisinpatientswithoralsquamouscellcarcinoma
AT chenmichaelyc fdgpetpredictsboneinvasionandprognosisinpatientswithoralsquamouscellcarcinoma